CYCLOBENZAPRINE HYDROCHLORIDE TABLETS

The Defense Logistics Agency awarded a delivery order under basic contract SPE2DX25D8022 to Cardinal Health, Inc. (CAGE 00E55) for the supply of Cyclobenzaprine Hydrochloride Tablets, identified by NSN 6505010628010, with a total contract value of $7.30. The order, issued on July 15, 2026, specifies the delivery of two bottles of the pharmaceutical product FOB destination to the USS HYMAN G. RICKOVER (SSN 795) at FPO AE 09591, with inspection and acceptance conducted by the government at the point of delivery. The contractor is designated as a Small Disadvantaged Women-Owned Business, with certifications in place under FAR 19.102 and DFARS 219.102, requiring compliance with SBA’s WOSB program and small business subcontracting reporting obligations. Payment will be processed through the Defense Finance and Accounting Service using code SL4701 to the remit address in Columbus, Ohio, with no specific invoicing method outlined beyond EDI references. The contract includes no additional line items, options, or extended pricing, and lacks detailed specification of packaging, barcoding, quality standards, or special contractual requirements such as security or conflict of interest clauses. The contracting officer is Lisa Quinn, and no Contracting Officer’s Representative is named. All packaging and documentation must bear the contract and delivery order numbers in block letters for identification. The award was made through a simplified acquisition under an IDIQ framework, with no solicitation or evaluation factors disclosed in the provided documentation.